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Abstract
Background: Despite a high prevalence of antenatal depression in low- and middle-income countries, there is very
little evidence for contextually adapted psychological interventions delivered in rural African settings. The aims of
this study are (1) to examine the feasibility of procedures for a future fully powered efficacy trial of contextually
adapted brief problem solving therapy (PST) for antenatal depression in rural Ethiopia, and (2) to investigate the
acceptability, fidelity and feasibility of delivery of PST in routine antenatal care.
Methods: Design: A randomised, controlled, feasibility trial and mixed method process evaluation. Participants:
Consecutive women attending antenatal clinics in two primary care facilities in rural Ethiopian districts. Eligibility
criteria: (1) disabling levels of depressive symptoms (Patient Health Questionnaire (PHQ-9) score of five or more and
positive for the 10th disability item); (2) gestational age 12–34 weeks; (3) aged 16 years and above; (4) planning to
live in the study area for at least 6 months; (5) no severe medical or psychiatric conditions. Intervention: Four
sessions of adapted PST delivered by trained and supervised antenatal care staff over a maximum period of eight
weeks. Control: enhanced usual care (EUC). Sample size: n = 50. Randomisation: individual randomisation stratified
by intimate partner violence (IPV). Allocation: central phone allocation. Outcome assessors and statistician masked
to allocation status. Primary feasibility trial outcome: dropout rate. Primary future efficacy trial outcome: change in
PHQ-9 score, assessed 9 weeks after recruitment. Secondary outcomes: anxiety symptoms, trauma symptoms,
intimate partner violence, disability, healthcare costs at 9 weeks; postnatal outcomes (perinatal and neonatal
complications, onset of breast feeding, child health) assessed 4–6 weeks postnatal. Other trial feasibility indicators:
recruitment, number and duration of sessions attended. Audio-recording of randomly selected sessions and in-
depth interviews with purposively selected participants, healthcare providers and supervisors will be analysed
thematically to explore the acceptability and feasibility of the trial procedures and fidelity of the delivery of PST.
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Discussion: The findings of the study will be used to inform the design of a fully powered efficacy trial of brief PST
for antenatal depression in routine care in rural Ethiopia.
Trial registration: The protocol was registered in the Pan-African clinical trials registry, (PACTR): registration
number: PACTR202008712234907 on 18/08/2020; URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=9578.
Keywords: Problem solving therapy, Antenatal depression, Psychological interventions, Perinatal mental health;
Ethiopia, Low- and middle-income countries
Introduction
Depression in the antenatal period is an important pub-
lic health challenge [1–3] which makes a substantial
contribution to maternal morbidity worldwide [4]. In
low- and middle-income countries (LMICs), depression
is estimated to adversely affect about 16% of pregnant
women [5, 6]. In our previous work in rural Ethiopia, de-
pression during pregnancy was associated with increased
use of emergency healthcare [7], increased perinatal
complications [8] and unplanned (emergency) institu-
tional delivery [9]. Antenatal depression has been associ-
ated with increased functional impairment [2, 10, 11],
somatic complaints [2, 12, 13] and reduced self-care
[14–16] in the pregnant woman, as well as greater
household food insecurity [17], delayed initiation of
breast-feeding [18], poor mother-infant attachment, ma-
ternal and child undernutrition [18, 19] and poor child
health [18].
Improved detection and treatment of antenatal depres-
sion in maternal care platforms, particularly within pri-
mary healthcare (PHC) settings, has been recommended
to reduce maternal morbidity [2, 12, 13], mortality
linked to suicide and adverse perinatal outcomes [20].
Although reducing maternal mortality and achieving
universal health coverage are key sustainable develop-
ment goals [21], integration of the detection and treat-
ment of antenatal depression into PHC-based maternal
care services has not been prioritised in many LMICs
[22]. Antidepressant medication has low acceptability in
pregnant women and is only appropriate for moderate-
severe depression [23, 24]. However, levels of depressive
symptoms that are associated with functional impair-
ment, but that do not necessarily meet criteria for a
diagnosis of major depressive disorder have been shown
to have adverse effects on the mother and unborn child
[25, 26] and can be treated effectively with psychological
treatments [27–30]. The World Health Organization
mental health gap (mhGAP) intervention guide, de-
signed for PHC workers in LMICs, recommends several
brief, manualised psychological therapies for people with
depression: interpersonal psychotherapy, cognitive be-
havioural therapy, behavioural activation therapy and
problem solving therapy (PST) [31]. These recommenda-
tions are largely based on findings from systematic
reviews and meta-analyses of randomised control trials
conducted in high-income countries (HICs) or in urban
settings in middle-income countries where there are
high levels of literacy [27–30]. These interventions are
not widely available in most LMICs, especially in rural
areas. Available evidence supports the effectiveness of
psychological interventions for ante- and postnatal de-
pression that focuses on social problems, female em-
powerment and involvement of child and family [27, 28],
and are delivered by non-specialist community and
healthcare workers [29] or peers [30] within the context
of routine maternal and child healthcare.
In Ethiopia, mental healthcare remains highly central-
ized, with mental health specialists located in urban hos-
pitals while more than 80% of the population lives in
rural areas. Furthermore, specialist mental healthcare fo-
cuses on severe mental illness, with little or no attention
given to antenatal depression. As a consequence, there is
a large treatment gap (96%) for perinatal depression in
Ethiopia [32]. Efforts to expand mental health care in
Ethiopia are underway, through integration in PHC and
maternal care platforms [33], but is hampered by the
lack of therapeutic options for depressed pregnant
women. Culturally and contextually relevant and scalable
psychological interventions are needed to address this
gap. In response to this need, we adapted problem solv-
ing therapy (PST) for a rural Ethiopian setting using the
Medical Research Council framework for development
and evaluation of complex interventions [34] and the
‘ADAPT-ITT’ approach [35].
PST focuses on improving a person’s ability to cope
with problems and stressful life experiences [36]. In
meta-analyses, PST has been found to be effective for
treatment of depression in comparison to no treatment
[37, 38]. However, there is limited evidence for PST for
antenatal depression in rural, low-income country set-
tings. PST was considered a good fit with the problem-
oriented nature of presentations of psychological distress
in antenatal care [39], the association of antenatal de-
pression with maladaptive problem-solving and poor
coping [40] and because of its simplicity, acceptability
and effectiveness in a low literacy population [37, 41–
43]. In our qualitative formative work [44], pregnant and
postpartum women and community healthcare workers
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perceived depressive symptoms as responses to situ-
ational challenges which may thus be amenable to psy-
chological interventions such as PST.
Objectives
In the proposed study, we aim to (1) examine the feasi-
bility of trial procedures for a future randomised con-
trolled trial of contextually-adapted brief PST for
antenatal depression in rural Ethiopia, and (2) investigate
the acceptability, fidelity and feasibility of delivery of
PST in routine antenatal care settings.
Methods
Setting
The study will be conducted in purposively selected pri-
mary healthcare facilities in Sodo and Kibet districts of
the Southern Nations, Nationalities and Peoples’ Region
(SNNPR). The primary healthcare facilities, primary hos-
pitals and health centres, are staffed by nurses, midwives
and health officers. Each health centre is linked to about
five health posts, community-based health facilities
staffed by health extension workers (HEWs). HEWs are
community-based healthcare workers who provide the
first antenatal contact, before referring women for
further ANC at a health centre or primary hospital, and
maintain contact with women during pregnancy.
The study sites are located 100–150 km south of
Addis Ababa, the capital city of Ethiopia. Kibet district is
in the Silte Zone. Sodo district is one of 15 districts in
the Gurage zone of SNNPR. Sodo is where the UK De-
partment for International Development-funded
Programme for Improving Mental Health carE (PRIME)
[45] worked with local leaders and stakeholders to de-
velop and implement a mental health care plan based on
task-shared mental health care delivered in primary and
maternal health care settings. The official language of
the region and in both districts is Amharic.
Study design
The proposed study is a randomised, controlled feasibil-
ity trial with two parallel groups and three time point as-
sessments: at baseline, nine weeks after recruitment and
4–6 weeks postnatal (Fig. 1). A mixed qualitative and
quantitative methods process evaluation will be nested
within the trial. A second feasibility trial involving a sub-
sample of trial participants who report past-year expos-
ure to intimate partner violence will be nested within
the trial; detailed in the published trial protocol [46].
Fig. 1 Participant recruitment procedures. Grey boxes indicate nested trial (Keynejad et al. 2020)
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Randomised, controlled feasibility trial
The randomised, controlled feasibility trial will compare
the adapted PST with enhanced usual care (EUC).
Eligibility criteria, participant recruitment procedures,
sample size and randomisation procedures, intervention
delivery, assessment and data analysis methods will be
described in the following sections.
Eligibility criteria
Inclusion criteria: Women can be included if they (1)
endorse elevated and disabling depression symptoms
(scoring 5 or more on the locally validated Patient
Health Questionnaire (PHQ-9) [47] and endorse im-
paired functioning on the 10th PHQ-9 item); (2) are be-
tween 12 and 34 weeks gestation; (3) are aged 16 years
and above, as this is the age at which married adolescent
women become legally autonomous in Ethiopia; (4) are
planning to live in the study area for at least 6 months;
and (5) speak Amharic (the official regional language).
Exclusion criteria: Women will be excluded if they (1)
present with acute medical illness or evidence of severe
mental illness; or (2) other comorbid medical conditions
such as hypertension or renal disease or diabetes; (3) en-
dorse the 9th item of the PHQ-9 indicating risk of sui-
cide and scoring more than 17 on the Mini International
Neuropsychiatric Interview (MINI) [48]; (4) require
emergency treatment; or [5] have a condition that im-
pairs their capacity to understand the interview (e.g. di-
agnosed with severe intellectual disability or dementia).
Participant recruitment and screening
Consecutive women attending primary health care-based
antenatal care in two primary care facilities will be the
target sample for recruitment into the study (Fig. 1) after
the research staff obtains informed consent. The re-
search staff will check initial eligibility of antenatal at-
tendees based on information available from the clinical
records (gestational age, age, co-morbid conditions and
residence). Eligible women will be invited to provide in-
formed consent to an initial screen for depressive symp-
toms associated with functional impairment using the
PHQ-9 and the PHQ-9 disability item. The disability
item asks ‘Over the last two weeks, how difficult have
these problems made it for you to do your work, take
care of things at home, or get along with other people?’
The response options are: ‘Not difficult at all’ = 0, ‘some-
what difficult’ = 1, ‘very difficult’ = 2 or ‘extremely diffi-
cult’ = 3. The MINI will be administered to women who
endorse any frequency of suicidality on the ninth item of
PHQ-9. Women with risk of suicide (MINI≥17) [48] will
be excluded from the study and referred for review by a
mental health-trained primary care worker [31] who will
employ mhGAP [49] to assess risk of suicide. The re-
search staff will facilitate women’s attendance of services
at the referral sites and their transportation costs to ac-
cess care.
Any woman who is found to be eligible following the
initial screen will receive written and verbal information
about the study from research staff and invited to par-
ticipate. Women who provide informed consent to par-
ticipate in the trial will receive a fully structured baseline
interview after receipt of their routine clinical care.
Participants’ costs incurred to attend research inter-
views and PST sessions will be reimbursed. Time spent
during research interviews will be compensated, but
time spent attending PST sessions will not be compen-
sated to avoid incentivising engagement with the inter-
vention. The healthcare workers will be compensated for
their additional effort in the trial.
Sample size
Fifty participants (25 in the intervention and 25 in the
enhanced usual care group) will be recruited for this
feasibility trial. This sample size will enable us to detect
a dropout rate of 7% with 95% confidence interval and a
5% margin of error [50]. A sample size of 24–50 is
recommended for feasibility studies [51].
Randomisation, allocation concealment and masking
Randomisation will be stratified by women’s report of
exposure to intimate partner violence, in order to ac-
commodate the nested feasibility trial [46]. Women with
disabling antenatal depressive symptoms but no expos-
ure to IPV will be randomised to one of two arms (the
PST intervention or enhanced usual care) using simple
randomisation in a 1:1 ratio. Women with both disabling
antenatal depression and intimate partner violence will
be randomised to one of three arms: the PST interven-
tion arm, enhanced usual care arm and a third arm of
PST adapted for women exposed to intimate partner
violence. Analysis of this third arm’s results will be con-
fined to the nested study (Fig. 1).
Central telephone randomisation will be used to con-
ceal allocation of the participants. A data manager in the
Centre for Innovative Drug Development and Thera-
peutic Trials for Africa (CDT-Africa), external to the
study, will allocate each participant to a study arm (PST,
PST adapted for women exposed to IPV or enhanced
usual care) using a random number list generated by a
statistician independent of the research team working in
the field (GM). Separate members of research staff based
in Sodo/Silte will telephone the data manager to arrange
allocation of each new participant. Whenever a new par-
ticipant has been allocated to that intervention, research
staff will inform a clinician trained to deliver the relevant
arm. Intervention and control groups will be
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anonymously coded so that the data analysts remain
masked during analysis. Participating women and health-
care providers will not be masked to allocation status
due to the nature of the intervention; however, outcome
assessors will be masked to allocation status.
PST intervention
PST is a commonly used psychotherapy [38, 52] that has
comparable efficacy to other psychotherapies such as be-
havioural activation, cognitive behavioural therapy and
social skills training and medication [53, 54]. The PST
approach assumes that depressive symptoms are the
negative consequences of maladaptive coping in re-
sponse to problems [55]. The intervention applies princi-
ples of evidence-based problem-solving therapy [55] to
improve a person’s problem solving and coping skills. In
this approach, there are three phases. In the first phase,
women are helped to identify the most important things
in their life. In the second phase, they identify a list of
problems that challenge attainment of important goals
in their life and classify the problems into three categor-
ies: ‘Problems that are upsetting but not relevant to the
most important things in one’s life’ (group A); ‘Problems
that are important but, insoluble’ (group B); and ‘import-
ant and soluble problems’ (group C). Any psychological
therapy should be adapted to the cultural setting to en-
sure effectiveness, acceptability and feasibility [56]. PST
has been contextually adapted and manualised for preg-
nant women with antenatal depressive symptoms in
rural Ethiopia (Bitew 2020, unpublished). The adaptation
was based on the Medical Research Council guidelines
for developing and evaluating complex interventions
[34] and the ADAP-ITT approach [35]. This comprised
a series of theory of change workshops, adaptation work-
shops and in-depth interviews with women with a his-
tory of perinatal depression and healthcare providers,
and discussions after role play (theatre test).
Participants randomised to the intervention arm will
receive four individual sessions of locally adapted and
manualised PST, along with enhanced usual care, at a
time convenient to them in a private room of the PHC
facility. Intervals between sessions will range from a
minimum of 2 days to a maximum of 2 weeks over a
period of 8 weeks ensuring that all sessions are com-
pleted during pregnancy. The first session will last for 1
h and the remaining sessions will last for approximately
40 min each.
The general approach to treatment is introduced in
the first session, during which the structure of PST is
fully explained, the participant identifies the most im-
portant priorities in her life and a list of her current
problems is established and classified into the three
problem categories: group A, group B and group C
problems. In each session, at least one ‘problem busting
session’ or ‘group C’ problem, important to the partici-
pant and that can potentially be solved, will be discussed
and the participant will agree a ‘take home activity’
based on that problem.
The second session will recap on the previous session,
review the outcome of the first take-home activity, intro-
duce problem solving strategies for problems categorised
as ‘group A’ and include one problem busting session
for a group C problem. The third session will review the
outcome of the second take-home activity, introduce
strategies for problems categorised as ‘group B’ and in-
clude one or two problem busting sessions for ‘group C’
problems. The final session will recap the third session
and include a problem busting session for any problems
which the participant wishes to prioritise.
Trained healthcare workers will deliver the interven-
tion under the supervision of an Ethiopian clinical or
counselling psychologist (master’s level) or psychiatrist/
psychiatric resident trained in psychological therapies.
Healthcare worker training will consist of (a) a 5-day
classroom-based training course which includes training
on counselling and communication skills as well as PST-
specific skills, and (2) accelerated delivery of four ses-
sions of PST, using high-intensity supervision and feed-
back to build competency [57, 58]. Competency will be
established using the Enhancing Assessment of Common
Therapeutic factors (ENACT) scale [57, 58] adminis-
tered by trained clinicians. The healthcare worker will
be required to score level 3 (‘Done Well’) out of the
three levels: (‘Done Well’, ‘Done partially’ and ‘Need im-
provement’) on each of the competencies in order to
participate in the trial. Feedback will be obtained from
women receiving the accelerated PST intervention in the
form of three structured questions with open-ended re-
sponses: (1) What parts of PST did you find helpful? (2)
What parts of PST were unhelpful/need to be improved?
How should they be improved? and (3) How convenient
was it for you to attend PST? How could this be im-
proved? All intervention sessions will be audio-recorded.
A random selection of sessions will be assessed by an ex-
pert who has been shown to rate reliably with kappa
greater than or equal to 0.80 for repeated scoring. A
checklist that contains five dimensions of fidelity [59]
will be adapted and used to assess the audio records and
then to give feedback focussed on intervention fidelity
and core competencies in PST and communication
skills. The five dimension of fidelity include (1) adher-
ence (extent to which program components such as pro-
gram content, methods and activities are delivered as
prescribed by the model); (2) exposure (number of ses-
sions or contacts, attendance and the frequency and dur-
ation of sessions); (3) quality of delivery (provider
enthusiasm, interaction style, respectfulness, confidence
and ability to respond to questions and communicate
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clearly); (4) participant responsiveness (participants’ level
of interest in the program; perceptions about the relevance
and usefulness of a program; and their level of engage-
ment, enthusiasm and willingness to engage in discussion
or activities); and (5) program differentiation (degree to
which the critical components of a program are distin-
guishable from each other and from other programs).
Clinical records and consent forms will be kept in the
research office for confidentiality. Research staff will use
telephone contact to follow up participants who with-
draw without reporting to the research office in order to
check for unreported adverse events.
Enhanced usual care
Participants allocated to the enhanced usual care arm will
receive usual antenatal care which focuses on advice about
reproductive and family health issues and information
about sources of general support. In addition, the Federal
Ministry of Health in Ethiopia has prepared evidence-
aligned guidelines on how to care for mental health prob-
lems in primary health care and maternal care settings
[60]. According to the guideline, primary healthcare staff
are expected to detect mental health problems and to pro-
vide basic mental healthcare (non-specific psychosocial
care for all and supervised prescription of antidepressant
medication depending on severity) [61]. All healthcare
providers participating in the trial will have been trained
in the World Health Organisation’s mhGAP for a mini-
mum of 5 days, as per the mental health scale-up plans of
the Federal Ministry of Health. As mhGAP has not been
implemented at scale in Ethiopia, this represents an
enhancement in usual care [62, 63].
Participants allocated to enhanced usual care and their
healthcare providers will be informed about the results
of screening and will receive an information sheet and
sources of general psychosocial support. These women
will attend three contacts: one pre-intervention assess-
ment and two follow-up assessments at 9 weeks after
recruitment and 4–6 weeks after childbirth.
Assessment of trial participant outcomes
A list of assessment variables and details about their
measurement is described in Table 1. Assessment will be
conducted at three time points: pre-intervention (T0;
baseline), 9 weeks after recruitment (T1; first follow-up)
and 4–6 weeks after delivery (T2; second follow-up).
The primary outcome for a future efficacy trial will be
change in PHQ-9 score using the locally validated Am-
haric version of PHQ-9 [64], assessed at T0, T1 and T2.
The PHQ-9 has been widely used as a clinical outcome
measure of treatment for depression [65, 66]. In
Ethiopia, PHQ-9 has been validated in antenatal women
[67] and in primary care settings in the neighbouring
district of the current study, with the optimal cut-off
point indicating probable depression identified as five or
more in primary care attendees [47]. At that cut-off,
PHQ-9 had a sensitivity of 83.3% and specificity of
74.7% for detection of major depressive disorder. In pre-
vious studies, a 50% reduction in PHQ-9 depressive
symptom scores [66] after 6–8 weeks was defined as
treatment response. A 50% reduction of PHQ-9 score at
nine weeks (T1) follow up will be defined as a treatment
response for future efficacy trial.
Secondary outcomes to be collected at T0, T1 and T2
are disability (change in WHO disability Assessment
Scale, WHODAS, score) [68], anxiety [Generalised
Anxiety Disorder-7 scale; GAD-7) [69], PTSD symptoms
checklist (PCL-5) [70, 71], intimate partner violence
(non-graphic IPV test with five items [72] and WHO
multi-country study questions [73]), number of emer-
gency healthcare visits and costs (locally adapted Client
Service Receipt Inventory (CSRI) [74]).
At T2, only (4 to 6 weeks postnatal) self-reported in-
formation on delivery setting, prolonged labour, sepsis,
unsafe abortion, perinatal mortality (stillbirth and neo-
natal mortality), time of onset of breast-feeding and
child health (maternal report of diarrhoea, fever and re-
fusal to breast feed) will be collected.
Potential mediators will be assessed at T0, T1 and T2:
attitudes towards gender roles (attitude towards gender
roles scale [75]), mastery (Multicultural mastery scale
[76]]), self-efficacy of coping with depression (adapted
self-efficacy scale [76]) and perceived social support
(Oslo Social Support Scale (OSS-3)), previously used in
Ethiopia [77] (Table 1).
At T0, a questionnaire will collect data about socio-
economic and demographic characteristics of the partici-
pants (age, education, marital status, age at marriage,
husband’s occupation and educational level, residence
and pregnancy intention), obstetric history, including
parity, pregnancy intention and gestational age, past psy-
chiatric history and list of traumatic experiences. An
item from Ethiopian Demographic Health Survey (EDHS
(previously used in our study [7]) will be used to assess
pregnancy intention.
Mixed quantitative and qualitative methods process
evaluation
A mixed quantitative and qualitative methods process
evaluation will be nested within the feasibility trial. The
aims are (1) evaluate the feasibility and acceptability of
trial procedures, and (2) to investigate the implementation
(feasibility, fidelity and acceptability) of delivery of PST.
Participants
Trial participant women, research assistants, supervisors
and intervention providers will be included in this mixed
study design.
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Sampling
Women who received the intervention will be purpos-
ively selected for semi-structured interview based on
their status of completion of the intervention sessions
(four sessions of PST). We estimate that about eight par-
ticipants, both who did and did not complete the PST
sessions, will be selected. However, the number of par-
ticipants will depend on when no new information is ob-
tained. All research assistants, supervisor and providers
will be invited to participate in the FGDs. Two separate
FGD sessions (one for providers and second for super-
visors and research assistants) will be conducted.
Process evaluation outcomes
The nested process evaluation investigates two categor-
ies of feasibility/implementation outcomes: trial
procedure feasibility and acceptability (see Table 2) and
implementation of delivery of PST (Table 3). The pri-
mary outcome for feasibility trial procedures is dropout
rate. Dropout will be defined as the number of women
lost to follow up at either of the follow up assessments.
Secondary outcomes related to trial procedures and data
collection procedures are listed in Table 2. These in-
clude participant recruitment rate, feasibility and suit-
ability of eligibility criteria, feasibility of data collection
procedures (clarity of baseline questionnaires, character-
istics of outcome measures such as missing data, time
needed to complete the questionnaires and data collec-
tion), adequacy of masking and practical administrative
challenges and acceptability of trial procedures (number
of refusals to recruitment and screening; qualitative
exploration of experience of trial procedures).
Table 1 Schedule of enrolment, interventions and assessments
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To document the successful implementation of an
intervention, the following implementation outcomes
are recommended: acceptability, adoption, appropriate-
ness, feasibility, fidelity, implementation cost and sus-
tainability [78] as detailed in Table 3.
Assessment
The primary outcome of the feasibility study, dropout
from the trial, will be documented as part of routine ad-
ministrative data. Administrative documents, log books,
FGD with research assistants and supervisors and pro-
ceedings of supervisory team will be used to document
data about these primary and secondary trial procedure
outcomes.
Two categories of assessment tools will be employed
to assess the PST delivery implementation outcomes: (1)
qualitative data (interview, FGD, audio recorded ses-
sions) and (2) assessment tools (outcome assessment
tools, Helping Alliance Questionnaire (HAQ), ENACT,
fidelity checklist). See Table 3 for an overall summary of
the data to be collected to document PST delivery im-
plementation outcomes. Semi-structured interviews will
be carried out with research assistants, supervisors and
participants who received the intervention and FGDs
with providers of the intervention to investigate accept-
ability and feasibility of the intervention delivery. Semi-
structured interviews with women who received the
intervention will make use of the same three structured
questions with open-ended responses that were used as
a competency check during provider training ((1) What
parts of PST did you find helpful? (2) What parts of PST
were unhelpful/need to be improved? How should they
be improved? and (3) How convenient was it for you to
attend PST? How could this be improved?). The inter-
view topic guides with participants will focus on any per-
ceived benefits of the intervention, challenges of
delivering and receiving the intervention and the
strengths and weaknesses of intervention delivery and
their experience of the intervention delivery.
Intervention sessions will be audio recorded and some
randomly selected participants’ sessions will be assessed.
Expert who rated the intervention sessions during pro-
vider training will rate the sessions using the checklist
described previously that contains five dimensions of fi-
delity [59]. FGD topic guides for providers, supervisor
and research assistants will focus on reflection of their
Table 2 Outcomes of trial procedures
Feasibility outcomes Data source Feasibility success Timing
Feasibility of recruitment
• Dropouts from the trial/completion of sessions screening logs, supervision minutes and
session records





▪ Feasibility and suitability of eligibility criteria restrictive/
too inclusive
Administrative (screening logs)
Proceedings of weekly supervision meeting
(Agenda: suitability of eligibility)
# of women excluded due
to each exclusion criteria
Pre-
intervention
Feasibility of data collection procedures
▪ Clarity of baseline questionnaires (layout, instructions,
order of tools))
Proceedings of weekly supervision meeting
(Agenda: clarity, time and acceptability of
items
20 minutes to complete




▪ Characteristics of outcome measures (SD of the
outcome and missing data)
Outcome assessment tools Less than 5% missing data Post
baseline
assessment
▪ Time needed to complete questionnaires (reasonable or
burden to participants)
Time recorded on questionnaire
FGD with supervisors and research
assistants
20 minutes to complete




• adequacy of masking of assessors and time needed to
collect and analyse the data
Administrative documents





▪ Practical administrative and resource challenges to
conduct the study (e.g. budget requirements, time, space,
staff, skill, intervention materials)
In-depth interviews with participants and





Acceptability of trial procedures
▪ Obstacles to recruitment (recruitment rates, number of
eligible patients, number of refusals and screenings)
Administrative data and qualitative data
from healthcare providers and participants
Proceedings of weekly supervision meeting
(Agenda: recruitment challenges)
Less than 10% refusal to be
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experiences about the intervention, including opportun-
ities and challenges related to intervention delivery in
routine settings.
Data collection procedures and quality
Double data entry will be used for the quantitative data.
Range checks will be done for data values. For qualita-
tive data, the data will be collected from multiple
sources (supervisors, research assistants, intervention
providers, women receiving the intervention) for tri-
angulation. Experienced qualitative data collectors with
master’s degree and above will conduct the semi-
structured interviews and facilitate the FGDs. Audio re-
cords of selected PST sessions, in-depth interviews to
elicit women’s feedback about delivery of the interven-




Descriptive statistics will be used to summarize trial
participant characteristics and future efficacy trial
outcomes. The proportion of each group meeting cri-
teria for treatment success (a 50% reduction of PHQ-9
score at T1) and mean change in PHQ-9 score will be
described for the two arms. All outcomes (measured at
T1 and T2) will be summarized for PST and enhanced
usual care arms. For continuous outcomes, the standard
deviation will be computed, to inform future sample size
calculations for the main study. Standard deviation will
be computed from participants for whom outcome mea-
sures are available without need of imputations. STAT
version 13 will be used to analyse the quantitative data.
Process evaluation outcomes
Descriptive statistics will be used to summarize charac-
teristics of participants and the primary outcome. PST
delivery implementation outcomes such as extent of
missing data, numbers of sessions attended, number of
homework activities attempted, rates of initial engage-
ment, providers’ fidelity to the intervention protocol and
rates of recruitment will be described using descriptives.
The transcripts will be coded for thematic analysis to
identify issues related to context, mechanisms and
Table 3 Implementation outcomes for delivery of PST
Implementation outcomes Data source Feasibility success Timing
Feasibility of PST




▪ Practical administrative and resource challenges to
conduct the study (e.g. budget requirements, time, space,
staff, skill, intervention materials)
Semi-structured interviews with participants and




▪ All adverse events, including both expected and
unexpected (identification, documentation, referral and
reporting)
Administrative data (notes in routine clinical data),
participant self-report, identified if the woman
drops out of the study.




Fidelity (adherence of therapist to contents, methods and
ethical standards)






Acceptability of intervention delivery
• Participants’ satisfaction with therapeutic services Helping alliance questionnaire (HAQ) [78] After
intervention
• Suitability of measures Proceedings of weekly supervision meeting and
FGD with research assistants
During
intervention




▪ Relevance of the intervention In-depth interviews (participants and healthcare
providers) [79], session records.
After
intervention
▪ Retention and follow up rates, number and duration of
sessions attended









Implementation costs locally adapted Client Service Receipt Inventory
(CSRI) [73]) and administrative data
During/post
intervention
Implementation strategy (task-shared psychological
intervention)
Therapist competence to deliver PST (ENACT scale
[56, 57])
90% or more done
well (3 points) on
each item
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implementation as suggested in key guidance for the sys-
tematic conduct of process evaluations of complex inter-
ventions [79].
Discussion
There is a need for rigorous studies to provide high-
quality evidence about psychological interventions [56]
in low-income countries. The MRC guidance for devel-
opment and evaluation of complex interventions [34]
recommends feasibility studies to optimize potential in-
terventions for future efficacy trials. Where feasibility
studies have been conducted, it has been found that this
leads to improved intervention and evaluation designs
for fully powered trials [80, 81]. We have previously de-
scribed the process followed to produce a contextually
appropriate adaptation of PST for women with antenatal
depression in a rural Ethiopian setting with a high bur-
den of social adversity and low literacy. In this paper, we
have detailed a proposal for a feasibility trial and process
evaluation study in order to test procedures for a future
trial and investigate implementation outcomes related to
the delivery of the PST intervention in routine antenatal
care settings. This is an essential step towards planning
a future fully powered randomised controlled trial. This
study may be limited by the need to pay health workers
to deliver the new intervention because it is not yet a
recognised part of their work; this compensation may
affect the assessment of future feasibility. Thus, we an-
ticipate a challenge in balancing the need to gain a
proof-of-concept by ensuring that the intervention is de-
livered optimally, against real-world applicability. Our
process evaluation may help us to identify potential solu-
tions to overcome challenges in a future efficacy trial.
Unforeseen geo-political events and the COVID-19 pan-
demic may compromise the conduct and completion of
this protocol as currently planned. Telephone interviews
and use of large rooms while using facemasks would be
options to reduce the effects of the pandemic during
data collection. Early indications of the high mental
health burden associated with the COVID-19 pandemic
(Ambaw et al. unpublished data, 2020) and the associ-
ated infection control measures mean that this study will
remain highly relevant to improving maternal care
outcomes.
Trial status
This is protocol version 1.0. This protocol has been pro-
spectively submitted to the Pan-African clinical trials
registry on 13 December 2019. Recruitment of partici-
pants is anticipated to commence in October, 2020. Any
proposed changes to the protocol will be submitted to
Ababa University ethics review boards and updated on
the pan-African clinical trials registry. Research staff will
inform trial participants, where required, and changes
will be discussed in the ultimate results publication. The
trial sponsor is Addis Ababa University, Addis Ababa,
Ethiopia.
Supplementary Information




ANC: Antenatal care; DSM-IV: Diagnostic statistical manual–IV; FGD: Focus
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